United States Direct-To-Consumer Genetic Testing Markets, Competition, Forecast and Opportunities, 2028F

Dublin, Aug. 09, 2023 (GLOBE NEWSWIRE) -- The "United States Direct-To-Consumer Genetic Testing Market - By Test Type, Technology, Sample, Distribution Channel, Region, Competition, Forecast and Opportunities, 2028" report has been added to ResearchAndMarkets.com's offering.

The United States Direct-To-Consumer Genetic Testing Market is on track for significant growth by 2028

This growth can be attributed to the increasing public awareness of the accessibility of direct-to-consumer genetic tests in both developed and developing countries, driving the expansion of the market.

Leading market players are focusing on developing top-notch direct-to-consumer genetic testing solutions that ensure accurate and reliable test results. Companies like 23andMe are making special marketing efforts to promote their direct-to-consumer genetic tests through both offline and online retail channels, offering appealing discounts and promotional offers to attract customers.

Genetic testing involves medical procedures that examine genetic alterations to confirm or disprove the presence of genetic disorders or assess a person's predisposition to certain conditions. Through direct-to-consumer genetic testing, customers can undergo genetic tests with minimal involvement from third-party healthcare professionals.

These tests are made available to potential customers through online and printed advertisements, allowing consumers to collect their genetic data without the need for a doctor's assistance. The ease of accessibility has driven the market growth since the early 2000s, with consumers being able to purchase genetic testing kits both online and offline through various distribution outlets.

Rising Demand for Personalized Direct-To-Consumer Genetic Testing Services Fuel Market Expansion

The statistics of the direct-to-consumer genetic testing market will profit from the pharmacogenetics field's rising popularity. One well-known use of gene-based personalization is in the field of pharmacogenetics, in which genetic variations determine the selection of a drug therapy that supports the growth of a company.

Furthermore, the evaluation and control of individualized tests is done through consumer comprehension. The service provider gives descriptive data on the test's analytic and clinical validity, which raises industry demand. Additionally, the cost of these customized testing is lower than that of conventional genetic examinations.

Moreover, findings from customized direct-to-consumer genetic tests can be promptly acquired using easy-to-use, non-invasive techniques. The aforementioned factors are anticipated to increase the direct-to-consumer genetic testing market share overall.

Rising Public Awareness Regarding Direct-To-Consumer (DTC) Genetic Testing is Driving Market Expansion

The rapid growth of direct-to-consumer genetic testing is being aided by the rise in the frequency of chronic diseases as well as the advent of customized testing kits for specialized therapeutic fields. The acceptance and modification of such services have boosted the demand for such kits.

Moreover, government awareness programs in the region are expected to boost awareness among individuals, which in turn drives the growth of the market throughout the forecast period. Furthermore, the availability of these kits on online platforms is expected to support the growth of the Direct-To-Consumer (DTC) Genetic Testing market during the forecast period 2024-2028.

The high cost of DTC Kits is Hampering the Growth of the US Direct-To-Consumer (DTC) Genetic Testing Market

The high cost of DTC genetic testing services is limiting the growth of the US Direct-To-Consumer Genetic testing market. Various manufacturers are focusing on product advancement & innovation and the integration of next-generation technologies to launch high-end direct-to-consumer tests, leading to high investment in manufacturing facilities along with high product prices

For instance, based on the complexity of the test and the severity of the disease, the cost of direct-to-consumer genetic tests varies from USD 100 to USD 3,000. Hence, the demand for genetic services across middle-income and developed regions in the United States is anticipated to limit the growth of the market.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the United States Direct-To-Consumer Genetic Testing Market.

  • Ancestry.com, LLC
  • Helix OpCo LLC
  • MyHeritage Ltd.
  • Living DNA
  • Direct Laboratory Services, LLC

Report Scope

United States Direct-To-Consumer Genetic Testing Market, By Test Type:

  • Ancestry & Relationship Testing
  • Predictive Testing
  • Nutrigenomic Testing
  • Carrier Testing
  • Skincare Testing
  • Others

United States Direct-To-Consumer Genetic Testing Market, By Technology:

  • Single Nucleotide Polymorphism (SNP) Chips
  • Targeted Analysis
  • Whole Genome Sequencing (WGS)
  • Others

United States Direct-To-Consumer Genetic Testing Market, By Sample:

  • Saliva
  • Urine
  • Blood
  • Others

United States Direct-To-Consumer Genetic Testing Market, By Distribution Channel:

  • Online
  • Offline

United States Direct-To-Consumer Genetic Testing Market, By Region:

  • North-East
  • Mid-West
  • West
  • South

For more information about this report visit https://www.researchandmarkets.com/r/vp9z6a

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.